UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression

Journal of medicinal chemistry, 2018-01, Vol.61 (2), p.462-481

2018

Volltextzugriff (PDF)

Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)

Journal of medicinal chemistry, 2019-02, Vol.62 (3), p.1420-1442

2019

Volltextzugriff (PDF)

Discovery of Novel Pyrrolo[2,3‑d]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors

Journal of medicinal chemistry, 2022-01, Vol.65 (2), p.1243-1264

2022

Volltextzugriff (PDF)

Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands

Journal of medicinal chemistry, 2018-01, Vol.61 (2), p.543-575

2018

Volltextzugriff (PDF)

Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein

Journal of medicinal chemistry, 2020-07, Vol.63 (14), p.7510-7528

2020

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of Novel Selenium-Containing Isocombretastatins and Phenstatins as Antitumor Agents

Journal of medicinal chemistry, 2017-09, Vol.60 (17), p.7300-7314

2017

Volltextzugriff (PDF)

Organometallic Gold(III) Complexes Similar to Tetrahydroisoquinoline Induce ER-Stress-Mediated Apoptosis and Pro-Death Autophagy in A549 Cancer Cells

Journal of medicinal chemistry, 2018-04, Vol.61 (8), p.3478-3490

2018

Volltextzugriff (PDF)

Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase

Journal of medicinal chemistry, 2016-05, Vol.59 (10), p.4948-4964

2016

Volltextzugriff (PDF)

An Update on Poly(ADP-ribose)polymerase‑1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy

Journal of medicinal chemistry, 2016-11, Vol.59 (21), p.9575-9598

2016

Volltextzugriff (PDF)

Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH)

Journal of medicinal chemistry, 2017-11, Vol.60 (22), p.9184-9204

2017

Volltextzugriff (PDF)

Discovery of Novel Dual-Target Inhibitor of Bromodomain-Containing Protein 4/Casein Kinase 2 Inducing Apoptosis and Autophagy-Associated Cell Death for Triple-Negative Breast Cancer Therapy

Journal of medicinal chemistry, 2021-12, Vol.64 (24), p.18025-18053

2021

Volltextzugriff (PDF)

DNA-Unresponsive Platinum(II) Complex Induces ERS-Mediated Mitophagy in Cancer Cells

Journal of medicinal chemistry, 2022-01, Vol.65 (1), p.520-530

2022

Volltextzugriff (PDF)

Identification of (R)‑N‑((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)‑1H‑indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B‑Cell Lymphomas

Journal of medicinal chemistry, 2016-11, Vol.59 (21), p.9928-9941

2016

Volltextzugriff (PDF)

Mitochondria-Targeted Lupane Triterpenoid Derivatives and Their Selective Apoptosis-Inducing Anticancer Mechanisms

Journal of medicinal chemistry, 2017-07, Vol.60 (14), p.6353-6363

2017

Volltextzugriff (PDF)

Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer

Journal of medicinal chemistry, 2014-08, Vol.57 (16), p.6949-6964

2014

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer Agents

Journal of medicinal chemistry, 2016-03, Vol.59 (5), p.1946-1959

2016

Volltextzugriff (PDF)

Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure

Journal of medicinal chemistry, 2018-02, Vol.61 (3), p.1031-1044

2018

Volltextzugriff (PDF)

Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations

Journal of medicinal chemistry, 2023-01, Vol.66 (1), p.777-792

2023

Volltextzugriff (PDF)

Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer

Journal of medicinal chemistry, 2017-12, Vol.60 (24), p.9990-10012

2017

Volltextzugriff (PDF)

Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy

Journal of medicinal chemistry, 2018-10, Vol.61 (19), p.8754-8773

2018

Volltextzugriff (PDF)

Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity

Journal of medicinal chemistry, 2022-02, Vol.65 (4), p.3667-3683

2022

Volltextzugriff (PDF)

Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment

Journal of medicinal chemistry, 2017-12, Vol.60 (24), p.10205-10219

2017

Volltextzugriff (PDF)

Discovery of a Dual Tubulin and Poly(ADP-Ribose) Polymerase‑1 Inhibitor by Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, and Biological Evaluation

Journal of medicinal chemistry, 2021-11, Vol.64 (21), p.15702-15715

2021

Volltextzugriff (PDF)

Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo

Journal of medicinal chemistry, 2021-02, Vol.64 (4), p.2077-2109

2021

Volltextzugriff (PDF)

Pyrrolo[2′,3′:3,4]cyclohepta[1,2‑d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types

Journal of medicinal chemistry, 2020-10, Vol.63 (20), p.12023-12042

2020

Volltextzugriff (PDF)

1 – 25 von 732

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology. Drug Treatments

Zeitschrift / SerieJournal Of Medicinal Chemistry

ThemaAntineoplastic Agents - Pharmacology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(732)
Mit Volltextzugriff
(732)

Publikationsform

Artikel
(732)

Sprache

Englisch
(732)

Erscheinungsjahr

n.n

Thema

Drug Screening Assays, Antitumor
(719)
Humans
(692)
Chemistry, Medicinal
(669)
Life Sciences & Biomedicine
(669)
Pharmacology & Pharmacy
(669)
Science & Technology
(669)
Structure-Activity Relationship
(622)
Antineoplastic Agents - Chemical Synthesis
(617)
Antineoplastic Agents - Chemistry
(558)
Cell Line, Tumor
(550)
Animals
(393)
Cell Proliferation - Drug Effects
(312)
Mice
(293)
Models, Molecular
(241)
Molecular Structure
(198)
Stereoisomerism
(148)
Female
(147)
Crystallography, X-Ray
(125)
Mice, Nude
(125)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(732)

Zeitschrift / Serie

J. Med. Chem
(7)
Journal Of Medical Chemistry
(1)

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression

Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)

Discovery of Novel Pyrrolo[2,3‑d]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors

Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands

Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein

Design, Synthesis, and Biological Evaluation of Novel Selenium-Containing Isocombretastatins and Phenstatins as Antitumor Agents

Organometallic Gold(III) Complexes Similar to Tetrahydroisoquinoline Induce ER-Stress-Mediated Apoptosis and Pro-Death Autophagy in A549 Cancer Cells

Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase

An Update on Poly(ADP-ribose)polymerase‑1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy

Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH)

Discovery of Novel Dual-Target Inhibitor of Bromodomain-Containing Protein 4/Casein Kinase 2 Inducing Apoptosis and Autophagy-Associated Cell Death for Triple-Negative Breast Cancer Therapy

DNA-Unresponsive Platinum(II) Complex Induces ERS-Mediated Mitophagy in Cancer Cells

Mitochondria-Targeted Lupane Triterpenoid Derivatives and Their Selective Apoptosis-Inducing Anticancer Mechanisms

Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer

Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer Agents

Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure

Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations

Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer

Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy

Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity

Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment

Discovery of a Dual Tubulin and Poly(ADP-Ribose) Polymerase‑1 Inhibitor by Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, and Biological Evaluation

Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo

Pyrrolo[2′,3′:3,4]cyclohepta[1,2‑d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types

Aktive Filter

Suchergebnisse filtern